Angiopoietins and diabetic nephropathy

Diabetologia

Volumn 59, Issue 8, 2016, Pages 1616-1620

  Gnudi, Luigi ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Albuminuria; Angiopoietin; Diabetes; Endothelial cells; Glomerulus; Review

Indexed keywords

ANGIOPOIETIN;

ALBUMINURIA; AUTOCRINE EFFECT; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; END STAGE RENAL DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; GLYCOCALYX; HUMAN; INTRACELLULAR SIGNALING; MESANGIUM; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; GLOMERULUS; METABOLISM; PATHOLOGY;

ALBUMINURIA; ANGIOPOIETINS; ANIMALS; DIABETIC NEPHROPATHIES; ENDOTHELIAL CELLS; HUMANS; KIDNEY GLOMERULUS;

EID: 84969833549     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3995-3     Document Type: Review

References (41)

1. Tryggvason K, Pikkarainen T, Patrakka J (2006) Nck links nephrin to actin in kidney podocytes. Cell 125:221–224
2. Greka A, Mundel P (2012) Cell biology and pathology of podocytes. Annu Rev Physiol 74:299–323
3. Boute N, Gribouval O, Roselli S et al (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–354
4. Kestila M, Lenkkeri U, Mannikko M et al (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582
5. Ichimura K, Stan RV, Kurihara H, Sakai T (2008) Glomerular endothelial cells form diaphragms during development and pathologic conditions. J Am Soc Nephrol 19:1463–1471
6. Brunskill EW, Potter SS (2010) Gene expression programs of mouse endothelial cells in kidney development and disease. PLoS One 5, e12034
7. Haraldsson B, Nystrom J, Deen WM (2008) Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 88:451–487
8. Salmon AH, Ferguson JK, Burford JL et al (2012) Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J Am Soc Nephrol 23:1339–1350
9. Suh JH, Miner JH (2013) The glomerular basement membrane as a barrier to albumin. Nat Rev Nephrol 9:470–477
10. Woolf AS, Gnudi L, Long DA (2009) Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 20:239–244
11. Kim KT, Choi HH, Steinmetz MO et al (2005) Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J Biol Chem 280:20126–20131
12. Brindle NP, Saharinen P, Alitalo K (2006) Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98:1014–1023
13. Suri C, Jones PF, Patan S et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171–1180
14. Jeansson M, Gawlik A, Anderson G et al (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 121:2278–2289
15. Gavard J, Patel V, Gutkind JS (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14:25–36
16. Thurston G, Suri C, Smith K et al (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511–2514
17. Maisonpierre PC, Suri C, Jones PF et al (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60
18. Hakanpaa L, Sipila T, Leppanen VM et al (2015) Endothelial destabilization by angiopoietin-2 via integrin beta1 activation. Nat Commun 6:5962
19. Findley CM, Cudmore MJ, Ahmed A, Kontos CD (2007) VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 27:2619–2626
20. Yuan HT, Suri C, Yancopoulos GD, Woolf AS (1999) Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J Am Soc Nephrol 10:1722–1736
21. Satchell SC, Harper SJ, Tooke JE, Kerjaschki D, Saleem MA, Mathieson PW (2002) Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 13:544–550
22. Yuan HT, Suri C, Landon DN, Yancopoulos GD, Woolf AS (2000) Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature. J Am Soc Nephrol 11:1055–1066
23. Long DA, Woolf AS, Suda T, Yuan HT (2001) Increased renal angiopoietin-1 expression in folic acid-induced nephrotoxicity in mice. J Am Soc Nephrol 12:2721–2731
24. Dessapt-Baradez C, Woolf AS, White KE et al (2014) Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J Am Soc Nephrol 25:33–42
25. Rizkalla B, Forbes JM, Cao Z, Boner G, Cooper ME (2005) Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. J Hypertens 23:153–164
26. Davis B, Dei CA, Long DA et al (2007) Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 18:2320–2329
27. Nakagawa T, Kosugi T, Haneda M, Rivard CJ, Long DA (2009) Abnormal angiogenesis in diabetic nephropathy. Diabetes 58:1471–1478
28. Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, Stewart DJ (2003) Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 162:1927–1936
29. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB (2005) Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 289:L371–381
30. Nakagawa T (2007) Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 292:F1665–F1672
31. Zhu J, Sun N, Aoudjit L et al (2008) Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int 73:556–566
32. Lim HS, Blann AD, Chong AY, Freestone B, Lip GY (2004) Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care 27:2918–2924
33. Chen S, Li H, Zhang C et al (2015) Urinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus. Int J Endocrinol 2015:163120
34. Tsai YC, Chiu YW, Tsai JC et al (2014) Association of angiopoietin-2 with renal outcome in chronic kidney disease. PLoS One 9, e108862
35. David S, John SG, Jefferies HJ et al (2012) Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 27:1867–1872
36. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG (2002) Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106:2085–2090
37. Chang FC, Chiang WC, Tsai MH et al (2014) Angiopoietin-2-induced arterial stiffness in CKD. J Am Soc Nephrol 25:1198–1209
38. Saharinen P, Alitalo K (2011) The yin, the yang, and the angiopoietin-1. J Clin Invest 121:2157–2159
39. Dei Cas A, Gnudi L (2012) VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment? Metabolism 61:1666–1673
40. Gnudi L, Benedetti S, Woolf AS, Long DA (2015) Vascular growth factors play critical roles in kidney glomeruli. Clin Sci (Lond) 129:1225–1236
41. Campochiaro PA, Sophie R, Tolentino M et al (2015) Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2. Ophthalmology 122:545–554